AL
ONC

Airain Ltd’s BeOne Medicines Ltd ONC Stock Holding History

Airain Ltd’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$281K Sell
6,250
-2,504
-29% -$98.7K 0.01% 675
2017
Q1 		$320K Buy
+8,754
New +$319K 0.02% 603

Other funds holding ONC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Airain Ltd's ONC Position: Q2 2017 in Review

Airain Ltd reduced its BeOne Medicines Ltd (ONC) stake by 29% in Q2 2017, selling an estimated $98.7K and leaving 6,250 shares worth $281K. The position accounts for 0.01% of the portfolio, ranked #675.

Airain Ltd first reported a position in ONC in Q1 2017 and has held it in 2 quarters since. The position peaked at $320K in Q1 2017. 57 funds tracked by Wall St. Rank hold ONC as of Q2 2017.

  • Airain Ltd held 6,250 shares of BeOne Medicines Ltd worth $281K as of Q2 2017.
  • Airain Ltd sold 2,504 BeOne Medicines Ltd shares in Q2 2017, an estimated $98.7K.
  • BeOne Medicines Ltd made up 0.01% of Airain Ltd's portfolio in Q2 2017, its #675 holding.
  • Airain Ltd first reported a position in BeOne Medicines Ltd in Q1 2017 and has held it in 2 quarters since.
  • Airain Ltd's BeOne Medicines Ltd position peaked at $320K in Q1 2017.
  • 57 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.